Analyst Ratings
Upgrades, downgrades, and price-target changes from Wall Street firms.
Analyst Ratings
B of A Securities Reiterates Buy on Guardian Pharmacy Services, Inc.
B of A Securities maintained its buy rating for Guardian Pharmacy Services with a $47 price target.
Analyst Ratings
HC Wainwright Reiterates Buy Rating on Opus Genetics
Opus Genetics receives a buy rating reiteration from HC Wainwright with an $8.00 target.
Analyst Ratings
Goldman Sachs Downgrades Ermenegildo Zegna to Hold
Goldman Sachs analyst Adrien Duverger downgrades Zegna to hold with a $14 target.
Analyst Ratings
Canaccord Genuity Reiterates Buy Rating on Central Garden & Pet
Canaccord Genuity maintains its buy rating for Central Garden & Pet with a $53 price target.
Analyst Ratings
Benchmark Reiterates Buy Rating on Cinemark Holdings
Benchmark maintains its buy rating for Cinemark Holdings, setting a $37 target price.
Analyst Ratings
Citizens Reiterates Buy Rating on Encore Capital Group, Inc.
Encore Capital Group, Inc. receives a buy rating from Citizens with a $115 price target.
Analyst Ratings
Citizens Reiterates Buy Rating for Sphere Entertainment Co.
Citizens has reaffirmed its buy rating on Sphere Entertainment Co. with a $200 price target.
Analyst Ratings
Truist Securities Reiterates Buy Rating on Guardian Pharmacy Services
Truist Securities maintains its Buy rating on Guardian Pharmacy Services with a $47 price target.
Analyst Ratings
Truist Securities Reiterates Buy Rating on Lineage, Inc.
Truist Securities maintains its buy stance on Lineage, Inc., setting a $46 price target.
Analyst Ratings
DA Davidson Reiterates Buy Rating on Open Lending
DA Davidson maintains its 'buy' rating for Open Lending with a $3.00 target.
Analyst Ratings
Mizuho Upgrades Huntsman Corporation to Hold
Mizuho raised its rating on Huntsman Corporation to hold, setting a $14 price target.
Analyst Ratings
Roth Capital Reiterates Buy Rating for NANO Nuclear Energy
Roth Capital maintains its buy rating on NANO Nuclear Energy with a $45 price target.
Analyst Ratings
B. Riley Securities Reaffirms Buy Rating for Service Properties Trust
Service Properties Trust maintains a buy rating from B. Riley Securities with a $2.50 price target.
Analyst Ratings
Freedom Broker Upgrades The Mosaic Company to 'Buy'
Freedom Broker has raised its rating for The Mosaic Company to 'buy' with a $32 price target.
Analyst Ratings
Freedom Broker Reiterates Buy Rating on Sanara MedTech
Freedom Broker maintains a 'buy' rating on Sanara MedTech with a $35 price target.
Analyst Ratings
LifeSci Capital Reiterates Buy Rating on Immix Biopharma
LifeSci Capital reaffirms its 'buy' rating on Immix Biopharma with a $19 price target.
Analyst Ratings
Maxim Group Reiterates Buy Rating for Oxbridge Re Holdings
Maxim Group maintains a buy rating on Oxbridge Re Holdings, targeting $3.00.
Analyst Ratings
UBS Reaffirms Buy Rating on Ultrapar Participações S.A.
UBS maintains its optimistic outlook on Ultrapar with a $7.20 price target.
Analyst Ratings
UBS Reiterates Buy Rating on UGP
UBS maintains a buy rating on UGP, setting a $7.2 price target.
Analyst Ratings
UBS Reiterates 'Buy' Rating for Constellation Brands
UBS analyst Peter Grom maintains a 'buy' rating with a $175 target on Constellation Brands.
Analyst Ratings
CIBC Reiterates Buy Rating on BlackBerry
CIBC maintains its buy rating on BlackBerry with a $10 target.
Analyst Ratings
Freedom Broker Upgrades MOS to Buy with $32 Price Target
Freedom Broker has raised its rating on MOS to a buy, setting a new price target of $32.
Analyst Ratings
Freedom Broker Reiterates Buy Rating on DNOW Inc.
Freedom Broker maintains its buy rating on DNOW Inc., targeting $16 per share.
Analyst Ratings
Freedom Broker Reiterates Buy Rating on SMTI
Freedom Broker has reiterated its buy rating for SMTI, with a price target of $35.